see three paths forward to ease the pain of long COVID. First, there is a burgeoning research program developing in academic and industry circles. From the National Institutes of Health’s Recover program to grass-roots nonprofit efforts like the Long COVID Research Initiative, we are designing robust studies to discover the truth about different medications, cognitive rehabilitation efforts, and more.
Second, we must all determine our own risk tolerance. Indoor public exposure to COVID is much less risky if masked. Regarding vaccination, one in three people across the world remains unvaccinated. Remember that COVID-related deaths in 2022 are five times lower in vaccinated than in unvaccinated people. In addition, vaccination lowers the risk of long COVID by as much as 75 to 85 percent, and the new bivalent B5 booster vaccineis now available.